In an industry that grapples with high failure rates, it’s important to recognize the successes and the hard work put in by biopharma companies as well as firms supporting those efforts. The Citeline Awards are our way to honor the research and development activity that drives the industry and meets the urgent needs of patients. The Awards are your chance to bring recognition and raise awareness of your innovative R&D work.
The deadline for entries is approaching. The submission fee is $99, which can be applied toward attendance at the event. The extended deadline is 28 February; for anyone needing an extension, please contact Natalia Kay (Natalia.kay@citeline.com).
Guidance on the submission process and details on the criteria for each award are available on the Citeline Awards website. All entries are judged by an independent panel of industry experts.
This year’s categories include:
- Excellence in Rare Disease Drug Development
- Most Successful Early Phase Research (Preclinical & Phase I)
- Champion of Diversity and Inclusion in Clinical Trials
- Clinical Research Team of the Year – Biotech (Open to Biotech Companies Only)
- Clinical Research Team of the Year – Pharma (Open to Pharma Companies Only)
- Clinical Partnership of the Year – Non-CRO
- CRO Partnership of the Year
- Innovative Clinical Trial Solutions
- Industry Achiever
- Clinical Trial Result of the Year (Open to Pharma & Biotech Companies only)
- Social/Community Development
The Awards will be presented on 8 May at the Hyatt Regency Boston, Downtown Boston Theater District Hotel. Help us celebrate outstanding contributions to the clinical landscape and gain global industry recognition.
